Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Takeda's new cephems

Feb. 4, 1997

Novel formulation of aciclovir enters pivotal trials

Jan. 31, 1997

Micrologix receives broad patent coverage for peptide antibiotic production method

Jan. 31, 1997

Novel antiinfective agents from Tanabe

Jan. 31, 1997

Bayer to market Amphotec in Canada

Jan. 30, 1997

Nobel Laureate to study bacterial resistance to nisin

Jan. 30, 1997

Famvir safe and effective in HIV-infected patients with shingles

Jan. 30, 1997

Microcide reports new cephalosporin antibiotics

Jan. 30, 1997

Synthelabo investigates oxazolidinones

Jan. 30, 1997

N-oxide antibacterial compounds from Bayer

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...